Use of specific doses of sodium fondanparic sodium for the treatment of ACS

摘要

The present invention relates to pentasacadlide methyl o - (2-deoxy-2-sulfoamino-6-o-sulfo -. Alpha. - D-glucopyranosyl) - (1. RAR. 4) - O - (. Beta. - d-glucopyranosyluronic acid) - (1. RAR. 4) - O - (2-deoxy-2-2) for the production of drugs for the treatment of acute coronary syndrome (ACS) Sulfoamino-3,6-di-o-sulfo -. Alpha. - D-glucopyranosyl - - (1. RAR. 4) - O - (2-o-sulfo -. Alpha. - l-dopranosyuracuronic acid) - - (1. RAR. 4) - 2-deoxy-2-sulfo-6-o-sulfo -. Alpha. - d-glucopyranoside or the use of a dose of 2.5 mg of pharmaceutically acceptable salt .